SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-28
DOI
10.3389/fphar.2022.1045179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
- (2021) Feng Xu et al. Molecular Therapy-Nucleic Acids
- Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
- (2020) Zedan Zhang et al. Cancer Cell International
- Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics
- (2020) Wei Guo et al. DNA AND CELL BIOLOGY
- Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
- (2020) Jinhui Liu et al. GENOMICS
- Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells
- (2020) Kalpana Tilekar et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Structure, function and regulation of mammalian glucose transporters of the SLC2 family
- (2020) Geoffrey D. Holman PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Power of two: Combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
- (2020) Kalpana Tilekar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Nomogram for predicting gastric cancer recurrence using biomarker gene expression
- (2019) Sang-Ho Jeong et al. EJSO
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- Correlations between the metabolic profile and 18F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients
- (2019) Karolien Vanhove et al. Scientific Reports
- An outcome model for human bladder cancer: A comprehensive study based on weighted gene co‐expression network analysis
- (2019) Yaoyi Xiong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immunotherapy: Cancer immunotherapy and the value of cure
- (2018) Joseph C. Del Paggio Nature Reviews Clinical Oncology
- Fructose fuels lung adenocarcinoma through GLUT5
- (2018) Yuanyuan Weng et al. Cell Death & Disease
- A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
- (2018) Igor Brikun et al. Clinical Epigenetics
- Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
- (2018) Shuhei Suzuki et al. Oncotarget
- RDM1 plays an oncogenic role in human lung adenocarcinoma cells
- (2018) Lu Tong et al. Scientific Reports
- Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
- (2018) Henrika Jodeleit et al. Disease Models & Mechanisms
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Altered cancer metabolism in mechanisms of immunotherapy resistance
- (2018) Rishab Ramapriyan et al. PHARMACOLOGY & THERAPEUTICS
- A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
- (2018) Fang Zhao et al. Clinical Epigenetics
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas
- (2017) Young Jun Chai et al. SURGERY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Anticancer agents interacting with membrane glucose transporters
- (2016) C. Granchi et al. MedChemComm
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Normalization of CD4 + T cell metabolism reverses lupus
- (2015) Yiming Yin et al. Science Translational Medicine
- ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis
- (2015) Jian Liu et al. Cell Reports
- Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report
- (2015) Jonai Pujol-Gimenez et al. Journal of Cancer
- Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
- (2015) Ang Yuan et al. Scientific Reports
- The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
- (2014) Andrew N. Macintyre et al. Cell Metabolism
- AMPK: Regulating Energy Balance at the Cellular and Whole Body Levels
- (2014) D. Grahame Hardie et al. PHYSIOLOGY
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
- (2013) Tiziano Tuccinardi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
- (2013) Y Storozhuk et al. BRITISH JOURNAL OF CANCER
- The SLC2 (GLUT) family of membrane transporters
- (2013) Mike Mueckler et al. MOLECULAR ASPECTS OF MEDICINE
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
- (2013) William A Flavahan et al. NATURE NEUROSCIENCE
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
- (2012) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Impact of GLUT1 and Ki-67 expression on early-stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification
- (2012) YUHO MAKI et al. ONCOLOGY REPORTS
- Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
- (2012) Yaryna Storozhuk et al. Radiation Oncology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
- (2011) Joanna Zawacka-Pankau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytoscape 2.8: new features for data integration and network visualization
- (2010) M. E. Smoot et al. BIOINFORMATICS
- Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells
- (2010) Toran Sanli et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Uric acid transport and disease
- (2010) Alexander So et al. JOURNAL OF CLINICAL INVESTIGATION
- Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size
- (2010) Naohisa Suzawa et al. LUNG CANCER
- Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
- (2010) Giovanni L Gravina et al. Molecular Cancer
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- GLUT7: a new intestinal facilitated hexose transporter
- (2008) Chris Cheeseman AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started